# Study to Explore the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AHT956 in Healthy Subjects

> **NCT00410228** · PHASE1 · COMPLETED · sponsor: **Novartis** · enrollment: 42 (—)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AHT956

## Key facts

- **NCT ID:** NCT00410228
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 42 (—)
- **Last updated:** 2007-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00410228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00410228, "Study to Explore the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AHT956 in Healthy Subjects". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00410228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*